两种透析方式均可选患者的生存比较:血透与腹透
该回顾性队列研究纳入加拿大安大略省7家透析中心2004至2013年起始透析且完成多学科模式评估的成人终末期肾病患者。在全体患者中,65岁以下者腹透与较低死亡风险相关;但排除约三分之一不适合腹透者后,两种模式生存相似,且该结果在择期门诊起始透析者中一致,效应不随时间变化。
要点
- 在两种模式均可选的患者中,血透与腹透的全因死亡风险相似。
- 未限制腹透资格时,65岁以下患者腹透显示较低死亡风险。
- 比较透析模式的研究应限定于两种模式均可选的人群。
核心结论
- 在两种模式均可选的起始透析患者中,血透与腹透的全因死亡风险相似。
- 模式对生存的效应不随时间变化。
研究设计与样本
- 全体起始患者包括1579例血透和453例腹透。
主要发现
- 在全体起始患者中,65岁以下者腹透与较低死亡风险相关。
- 排除约三分之一不适合腹透的患者后,无论年龄,两种模式生存相似。
- 在择期门诊起始透析的患者中,同样观察到两种模式生存相似。
临床怎么用
- 临床选择透析模式时,对于两种模式均可选的患者,血透与腹透的生存获益相似。
- 评估透析模式对生存的影响时,应限定于两种模式均可选的人群。
局限性
- 腹透资格的判定基于各透析中心多学科团队的判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although peritoneal dialysis (PD) costs less to the health care system compared to in-center hemodialysis (HD), it is an underused therapy. Neither modality has been consistently shown to confer a clear benefit to patient survival. A key limitation of prior research is that study patients were not restricted to those eligible for both therapies. STUDY DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: All adult patients developing end-stage renal disease from January 2004 to December 2013 at any of 7 regional dialysis centers in Ontario, Canada, who had received at least 1 outpatient dialysis treatment and had completed a multidisciplinary modality assessment. PREDICTOR: HD or PD. OUTCOMES: Mortality from any cause. RESULTS: Among all incident patients with end-stage renal disease (1,579 HD and 453 PD), PD was associated with lower risk for death among patients younger than 65 years. However, after excluding approximately one-third of all incident patients deemed to be ineligible for PD, the modalities were associated with similar survival regardless of age. This finding was also observed in analyses that were restricted to patients initiating dialysis therapy electively as outpatients. The impact of modality on survival did not vary over time. LIMITATIONS: The determination of PD eligibility was based on the judgment of the multidisciplinary team at each dialysis center. CONCLUSIONS: HD and PD are associated with similar mortality among incident dialysis patients who are eligible for both modalities. The effect of modality on survival does not appear to change over time. Future comparisons of dialysis modality should be restricted to individuals who are deemed eligible for both modalities to reflect the outcomes of patients who have the opportunity to choose between HD and PD in clinical practice.
引用
- Wong B, Ravani P, Oliver MJ, et al. Comparison of Patient Survival Between Hemodialysis and Peritoneal Dialysis Among Patients Eligible for Both Modalities. Am J Kidney Dis. 2017. PMID: 29174322. doi:10.1053/j.ajkd.2017.08.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。